NEWS

AmCham at Arendalsuka 2023 – Multinationals in Norway: Patients, Innovation & Profit  

Category: AmCham News

AmCham at Arendalsuka 2023 – Multinationals in Norway: Patients, Innovation & Profit This year at Arendalsuka, AmCham hosted a crowded meeting at Clarion Tyholmen addressing the central question: “Is the Norwegian healthcare sector competitive?” AmCham members represent 21 industries, with a significant number within the healthcare industry. In Arendal, our panellists debated the progress made […]

Source: AmCham Norway

Published: July 15, 2025

The Norwegian State Budget 2023 – What Do International Companies Need to Know?

Category: AmCham News

On October 6th, Norway’s minority center-left coalition government formed by the Labor and Center Parties presented its proposal for the 2023 National Budget. Less Government Pension Fund spending, changes in income tax, continued electricity subsidies, and strengthening of National security are some of the notable features. AmCham Norway and Hill+Knowlton Norge have summarized the proposed […]

Source: AmCham & Hill+Knowlton

ACE US Week: Washington DC Virtual Outreach

Category: AmCham News

As the current circumstances have again prevented the ACE representatives from traveling to the U.S. to meet with each other and with relevant stakeholders, ranging from private and international organizations to key government agencies, they had the opportunity to meet with Washington DC partners through a series of virtual sessions in the scope of ACE-US Week: […]

Source: AmChams in Europe

AmCham deltar i Stortingets Helsekomite-høring

Category: AmCham Norway

— AmCham ser ingen grunn til at det skal være ulikt for offentlige anskaffelser av legemidler i forhold til anskaffelser i andre sektorer, eller helsesektoren for øvrig, sa Katja Dahl Murphy, Myndighetskontakt i AmCham Norway, på høringen om konfidensielle legemiddelpriser i regi av Stortingets Helse- og omsorgskomite tidligere i dag (torsdag). — Konfidensialitet rundt enhetspriser […]

Source: AmCham

AmCham Appears Before Parliamentary Health Committee Hearing

Category: AmCham Norway

“AmCham sees no particular reason why there should be a difference in the public procurement of pharmaceuticals as compared to procurements within other sectors – or the health sector in general,” said Katja Dahl Murphy, AmCham’s Member & Government Affairs Consultant, during a hearing examining the confidentiality of pharmaceutical discount pricing at the Parliament earlier […]

Source: AmCham